Skip to main content
. 2015 Feb 10;138(4):1023–1035. doi: 10.1093/brain/awv007

Table 1.

Demographics, baseline and final assessment

Aβ− MCI Aβ+ MCI
Baseline assessment n 16 17
gender (% female) 19 24 chi = 0.57
age 72 ± 1.91 74 ± 2.03 P = 0.57
years of education 16 ± 0.64 17 ± 0.51 P = 0.21
APOE (% ε4 carriers) 38 50 chi = 0.58a
Amyloid-β (PiB/FLR) 1.1 ± 0.02 1.6 ± 0.05 P < 0.001b
CDR 0.5 0.5
LMIIa 7.6 ± 1.32 5.0 ± 0.89 P = 0.12
MMSE 27.9 ± 0.33 26.9 ± 0.47 P = 0.11
Hippocampal fMRI 0.15 ± 0.037 0.31 ± 0.058 P = 0.024
Hippocampal volume 7197 ± 281 6287 ± 238 P = 0.019
CDRSB 1.3 ± 0.16 1.9 ± 0.25 P = 0.055
Final assessment LMIIa 10.25 ± 1.48 6.1 ± 1.6 P = 0.064
MMSE 27.9 ± 0.51 26.2 ± 0.54 P = 0.037
Hippocampal fMRI 0.10 ± 0.038 0.27 ± 0.068 P = 0.039
Hippocampal volume 7045 ± 285 6009 ± 273 P = 0.013
CDRSB 1.5 ± 0.22 3.2 ± 0.41 P = 0.001

APOE = carriers of apolipoprotein E (APOE) ε4 allele; LMIIa = the Wechsler Memory Scale-Revised Logical Memory Test delayed recall; MMSE = Mini-Mental State Examination; CDRSB = Clinical Dementia Rating Sum of Boxes score; PiB = Pittsburg Compound-B (PiB) retention in neocortical regions of interest comprised of frontal, lateral temporal and retrosplenial (FLR) cortex.

P-values denote t-test or chi-squares test.

aAPOE genotype available in 23 MCIs.

bUsed to catogorize Aβ−/Aβ+ MCI groups.